Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis

(2022) Amanda L. Stapleton et al.   Journal of Cystic Fibrosis

Research letter: The impact of elexacaftor/tezacaftor/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis

(2022) Jia Tong Song et al.   Journal of Cystic Fibrosis

Elexacaftor-Tezacaftor-Ivacaftor improve Gastro-Oesophageal reflux and Sinonasal symptoms in advanced cystic fibrosis

(2022) Sufyan Shakir et al.   Journal of Cystic Fibrosis

Chest computed tomography improvement in patients with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: Early report

(2022) Romain Bec et al.   EUROPEAN JOURNAL OF RADIOLOGY

Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

(2021) Pierre-Régis Burgel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Peripheral lung effect of elexacaftor/tezacaftor/ivacaftor in adult cystic fibrosis

(2021) Dimitri Stylemans et al.   Journal of Cystic Fibrosis

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

(2021) Peter J. Barry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases

(2021) Angelica Tiotiu et al.   Expert Review of Respiratory Medicine

Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis

(2021) David P Nichols et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Lung inflammation and simulated airway resistance in infants with cystic fibrosis

(2021) Emily M. DeBoer et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for ≥24 Weeks in People With CF and ≥1 F508del Allele: Interim Results of an Open-Label Phase Three Clinical Trial

(2020) Matthias Griese et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement

(2019) Brian L. Graham et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

(2019) Harry G M Heijerman et al.   LANCET

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

(2019) Peter G. Middleton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantification of shape of flow-volume loop of healthy preschool children and preschool children with wheezing disorders

(2012) Véronique Nève et al.   PEDIATRIC PULMONOLOGY